Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection.

Article Details

Citation
Copy to clipboard

Maggio R, Corsini GU

Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection.

Pharmacol Res. 2020 Jul;157:104837. doi: 10.1016/j.phrs.2020.104837. Epub 2020 Apr 22.

PubMed ID
32334052 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
BromhexineTransmembrane protease serine 2ProteinHumans
Unknown
Not AvailableDetails